Colorectal cancer Clinical Trials
Recruiting colorectal cancer studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat colorectal cancer. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting colorectal cancer studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting colorectal cancer trials
Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization
CPHARM - CRC Study
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS)
A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers
Nutritional Supplementation to Improve Colorectal Cancer Surgery
Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors
Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer
A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
Triton 1.5 Robotic System for Diagnostic Colonoscopy
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Colorectal Cancer Screening in the Homeless
Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their Disease
Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients
TCR1188-ABC Cells in KRAS-mutated Cancers
A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Qigong Exercise for Muscles Strength and Quality of Life in Colorectal Cancer Patients Undergoing Chemotherapy
Evaluation of XYA02 in Patients With Advanced Solid Tumors
Development and Validation of a Colorectal Cancer Diagnostic Model
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
SL-28 for Advanced Solid Tumours
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
The PharmFIT Study
Preventing Early-Onset Colorectal Cancer in the VA
Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC
Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The Colorectal Regular-Irregular Score
A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors
The Correlation of Postoperative Polyp Recurrence and Colorectal Cancer
Effect of Video Training on Patients' Self-Efficacy After Colorectal Surgery
Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial
Optimising Colorectal Cancer Patient Pathways
Guardant Shield Colorectal Cancer Screening
A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Precision Navigation to Improve Community Cancer Screening Participation
[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Evaluation of Skin Tests in Biotherapy Allergies
Liquid Biopsy in Early Colorectal Lesions
Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer
An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy
Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor
Health Behavior Intervention for Colorectal Cancer Patients
A Study of a Urine Test to Detect Colorectal Cancer
Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy
Nudging Preventive Screening Via Message Framing and Bundling
MAP- Versus Cardiac Index-Guided Hemodynamic Management in Colorectal Surgery
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNA
A Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal Cancer Liver Metastases
Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.
The Implementation of Genetic Risk for Colorectal Cancer Screening
Transversus Abdominis Plane and Rectus Sheath Block for Robotic Colectomy
Glucose Homeostasis and Shared Genetic Factors in Colorectal Cancer
Colorectal cancer clinical trials — common questions
Are colorectal cancer clinical trials free to join?
Yes. Participating in a colorectal cancer clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a colorectal cancer clinical trial?
Each colorectal cancer study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a colorectal cancer trial near me?
Use the location controls above. We'll show recruiting colorectal cancer trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many colorectal cancer trials are recruiting right now?
We're currently tracking roughly 238 recruiting colorectal cancer trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.